TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Cypromed AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
47,190
|
41,230
|
35,914 |
| Financial expenses |
211
|
133
|
56 |
| Earnings before taxes |
6,311
|
6,474
|
5,929 |
| Total assets |
24,556
|
26,215
|
21,045 |
| Current assets |
22,111
|
25,472
|
20,307 |
| Current liabilities |
15,007
|
17,446
|
13,178 |
| Equity capital |
9,549
|
8,769
|
7,867 |
| - share capital |
562
|
562
|
562 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.9%
|
33.5%
|
37.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
13.4%
|
15.7%
|
16.5% |
| Return on assets (ROA) |
26.6%
|
25.2%
|
28.4% |
| Current ratio |
147.3%
|
146.0%
|
154.1% |
| Return on equity (ROE) |
66.1%
|
73.8%
|
75.4% |
| Change turnover |
5,960
|
5,316
|
3,007 |
| Change turnover % |
14%
|
15%
|
9% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.